...
首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia.
【24h】

Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia.

机译:蛋白酶激活的受体2使辣椒素受体瞬态受体潜在的香草样受体1致敏,引起痛觉过敏。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Inflammatory proteases (mast cell tryptase and trypsins) cleave protease-activated receptor 2 (PAR2) on spinal afferent neurons and cause persistent inflammation and hyperalgesia by unknown mechanisms. We determined whether transient receptor potential vanilloid receptor 1 (TRPV1), a cation channel activated by capsaicin, protons, and noxious heat, mediates PAR2-induced hyperalgesia. PAR2 was coexpressed with TRPV1 in small- to medium-diameter neurons of the dorsal root ganglia (DRG), as determined by immunofluorescence. PAR2 agonists increased intracellular [Ca2+] ([Ca2+]i) in these neurons in culture, and PAR2-responsive neurons also responded to the TRPV1 agonist capsaicin, confirming coexpression of PAR2 and TRPV1. PAR2 agonists potentiated capsaicin-induced increases in [Ca2+]i in TRPV1-transfected human embryonic kidney (HEK) cells and DRG neurons and potentiated capsaicin-induced currents in DRG neurons. Inhibitors of phospholipase C and protein kinase C (PKC) suppressed PAR2-induced sensitization of TRPV1-mediated changes in [Ca2+]i and TRPV1 currents. Activation of PAR2 or PKC induced phosphorylation of TRPV1 in HEK cells, suggesting a direct regulation of the channel. Intraplantar injection of a PAR2 agonist caused persistent thermal hyperalgesia that was prevented by antagonism or deletion of TRPV1. Coinjection of nonhyperalgesic doses of PAR2 agonist and capsaicin induced hyperalgesia that was inhibited by deletion of TRPV1 or antagonism of PKC. PAR2 activation also potentiated capsaicin-induced release of substance P and calcitonin gene-related peptide from superfused segments of the dorsal horn of the spinal cord, where they mediate hyperalgesia. We have identified a novel mechanism by which proteases that activate PAR2 sensitize TRPV1 through PKC. Antagonism of PAR2, TRPV1, or PKC may abrogate protease-induced thermal hyperalgesia.
机译:炎性蛋白酶(肥大细胞类胰蛋白酶和胰蛋白酶)裂解脊髓传入神经元上的蛋白酶激活受体2(PAR2),并通过未知机制引起持续性炎症和痛觉过敏。我们确定瞬态受体潜在的香草类受体1(TRPV1),辣椒素,质子和有毒的热量激活的阳离子通道介导PAR2诱导的痛觉过敏。通过免疫荧光测定,PAR2与TRPV1在背根神经节(DRG)的中小直径神经元中共表达。 PAR2激动剂在培养的这些神经元中增加了细胞内[Ca2 +]([Ca2 +] i),并且PAR2反应性神经元也对TRPV1激动剂辣椒素有反应,证实了PAR2和TRPV1的共表达。 PAR2激动剂增强了辣椒素诱导的TRPV1转染的人胚肾(HEK)细胞和DRG神经元中[Ca2 +] i的增加,并增强了辣椒素诱导的DRG神经元中的电流。磷脂酶C和蛋白激酶C(PKC)的抑制剂抑制PAR2诱导的TRPV1介导的[Ca2 +] i和TRPV1电流变化的敏化。 PAR2或PKC的激活诱导了HEK细胞中TRPV1的磷酸化,表明该通道的直接调节。足底注射PAR2激动剂引起持续的热痛觉过敏,可通过拮抗作用或删除TRPV1来预防。非痛觉过敏剂量的PAR2激动剂和辣椒素共同注射可引起痛觉过敏,该现象被TRPV1缺失或PKC拮抗所抑制。 PAR2激活还增强了辣椒素诱导的P物质和降钙素基因相关肽从脊髓背角超融合部分的释放,它们介导痛觉过敏。我们已经确定了激活PAR2的蛋白酶通过PKC致敏TRPV1的新机制。 PAR2,TRPV1或PKC的拮抗作用可消除蛋白酶引起的热痛觉过敏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号